Tracking tumor changes in esophageal cancer with advanced testing
Part of Cancer, Digestive system clinical trials.
This study tracks changes in your tumor over time using advanced tests on blood and tissue samples. The goal is to better understand your cancer and help guide treatment for you and future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 79 years old and are in good general health (able to do daily activities).
- You have been diagnosed with esophageal squamous cell carcinoma (a type of esophageal cancer).
- For the surgical group: you have completed standard chemotherapy or radiation before surgery and are scheduled for or have had surgery to remove the tumor.
- For the advanced cancer group: you have not yet received any treatment for advanced disease (you are starting first-line therapy).
- You are willing to provide tissue samples (from biopsy or surgery) and to be followed up at the study center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving additional immunotherapy after esophageal cancer surgery can help prevent the cancer from coming back. If you've already had chemotherapy and immunotherapy before surgery, this trial may offer a way to continue that benefit after your operation.
This study compares two standard approaches for treating esophageal cancer before surgery: chemotherapy combined with radiation versus chemotherapy combined with immunotherapy. The goal is to see which approach works better for shrinking tumors and improving outcomes in patients whose cancer is considered removable.
This trial tests giving immunotherapy (PD-1 inhibitors) along with local treatments like radiation or surgery at different times for patients whose esophageal cancer has spread to only a few spots. The goal is to see the best timing for these combined treatments.
This trial tests a treatment plan that combines immunotherapy with chemotherapy before possible endoscopic surgery. It is for people with a specific type of esophageal cancer that has not been treated before and is either potentially removable or not suitable for standard surgery.
This study looks back at patients who received immunotherapy and chemotherapy before surgery for esophageal cancer, to see how often the cancer comes back after surgery. It may help doctors understand which patients benefit the most from this treatment approach.
This trial tests whether adding two immunotherapy drugs to standard chemotherapy and radiation before surgery can help shrink esophageal cancer and improve outcomes. It is for people with a certain type of esophageal cancer that can be removed with surgery.
Hear when a new Esophageal Squamous Cell Carcinoma (ESCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.